vs
Side-by-side financial comparison of Chatham Lodging Trust (CLDT) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $67.7M, roughly 1.4× Chatham Lodging Trust). Vericel Corp runs the higher net margin — 25.0% vs 6.8%, a 18.2% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -9.8%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -0.5%).
Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
CLDT vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $67.7M | $92.9M |
| Net Profit | $4.6M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 15.9% | 24.1% |
| Net Margin | 6.8% | 25.0% |
| Revenue YoY | -9.8% | 23.3% |
| Net Profit YoY | 369.9% | 17.3% |
| EPS (diluted) | $0.05 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $67.7M | $92.9M | ||
| Q3 25 | $78.4M | $67.5M | ||
| Q2 25 | $80.3M | $63.2M | ||
| Q1 25 | $68.6M | $52.6M | ||
| Q4 24 | $75.1M | $75.4M | ||
| Q3 24 | $87.2M | $57.9M | ||
| Q2 24 | $86.5M | $52.7M | ||
| Q1 24 | $68.4M | $51.3M |
| Q4 25 | $4.6M | $23.2M | ||
| Q3 25 | $3.5M | $5.1M | ||
| Q2 25 | $5.4M | $-553.0K | ||
| Q1 25 | $1.5M | $-11.2M | ||
| Q4 24 | $-1.7M | $19.8M | ||
| Q3 24 | $4.3M | $-901.0K | ||
| Q2 24 | $6.8M | $-4.7M | ||
| Q1 24 | $-5.2M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | 40.7% | 77.6% | ||
| Q3 24 | 44.7% | 71.9% | ||
| Q2 24 | 46.1% | 69.5% | ||
| Q1 24 | 38.9% | 68.9% |
| Q4 25 | 15.9% | 24.1% | ||
| Q3 25 | 12.7% | 5.1% | ||
| Q2 25 | 14.8% | -3.2% | ||
| Q1 25 | 12.1% | -24.3% | ||
| Q4 24 | 7.5% | 24.5% | ||
| Q3 24 | 14.3% | -4.3% | ||
| Q2 24 | 16.3% | -11.5% | ||
| Q1 24 | 1.4% | -10.7% |
| Q4 25 | 6.8% | 25.0% | ||
| Q3 25 | 4.5% | 7.5% | ||
| Q2 25 | 6.7% | -0.9% | ||
| Q1 25 | 2.2% | -21.4% | ||
| Q4 24 | -2.3% | 26.3% | ||
| Q3 24 | 4.9% | -1.6% | ||
| Q2 24 | 7.9% | -8.9% | ||
| Q1 24 | -7.6% | -7.5% |
| Q4 25 | $0.05 | $0.46 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $0.07 | $-0.01 | ||
| Q1 25 | $-0.01 | $-0.23 | ||
| Q4 24 | $-0.08 | $0.40 | ||
| Q3 24 | $0.05 | $-0.02 | ||
| Q2 24 | $0.10 | $-0.10 | ||
| Q1 24 | $-0.15 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.4M | $137.5M |
| Total DebtLower is stronger | $338.9M | — |
| Stockholders' EquityBook value | $740.8M | $354.6M |
| Total Assets | $1.2B | $488.0M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.4M | $137.5M | ||
| Q3 25 | $13.2M | $135.4M | ||
| Q2 25 | $17.2M | $116.9M | ||
| Q1 25 | $18.6M | $112.9M | ||
| Q4 24 | $20.2M | $116.2M | ||
| Q3 24 | $19.3M | $101.7M | ||
| Q2 24 | $10.6M | $102.5M | ||
| Q1 24 | $72.3M | $110.6M |
| Q4 25 | $338.9M | — | ||
| Q3 25 | $338.8M | — | ||
| Q2 25 | $351.2M | — | ||
| Q1 25 | $381.1M | — | ||
| Q4 24 | $406.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $740.8M | $354.6M | ||
| Q3 25 | $749.4M | $321.9M | ||
| Q2 25 | $754.1M | $306.8M | ||
| Q1 25 | $754.7M | $295.5M | ||
| Q4 24 | $758.2M | $292.0M | ||
| Q3 24 | $765.3M | $257.5M | ||
| Q2 24 | $766.5M | $243.0M | ||
| Q1 24 | $765.0M | $233.9M |
| Q4 25 | $1.2B | $488.0M | ||
| Q3 25 | $1.2B | $453.3M | ||
| Q2 25 | $1.2B | $435.6M | ||
| Q1 25 | $1.2B | $424.6M | ||
| Q4 24 | $1.3B | $432.7M | ||
| Q3 24 | $1.3B | $390.4M | ||
| Q2 24 | $1.3B | $376.8M | ||
| Q1 24 | $1.3B | $356.7M |
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.1M | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 13.90× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.1M | $15.0M | ||
| Q3 25 | $25.6M | $22.1M | ||
| Q2 25 | $22.1M | $8.2M | ||
| Q1 25 | $4.2M | $6.6M | ||
| Q4 24 | $73.8M | $22.2M | ||
| Q3 24 | $28.8M | $10.2M | ||
| Q2 24 | $25.2M | $18.5M | ||
| Q1 24 | $6.9M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | 13.90× | 0.65× | ||
| Q3 25 | 7.24× | 4.35× | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 2.73× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 6.78× | — | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLDT
| Occupancy | $61.5M | 91% |
| Hotel Other | $4.2M | 6% |
| Food And Beverage | $1.8M | 3% |
| Hotel | $1.1M | 2% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
